Differential Effects of the Dual Orexin Receptor Antagonist Almorexant and the GABAA-α1 Receptor Modulator Zolpidem, Alone or Combined with Ethanol, on Motor Performance in the Rat

Orexin Receptor Antagonism, a New Sleep-Promoting Paradigm: An Ascending Single-Dose Study With Almorexant

(2010) P Hoever et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Dose effects of triazolam and alcohol on cognitive performance in healthy volunteers.

(2010) Bethea A. Kleykamp et al.   EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY

Intact learning and memory in rats following treatment with the dual orexin receptor antagonist almorexant

(2010) Hendrik Dietrich et al.   PSYCHOPHARMACOLOGY

Orexin/hypocretin modulation of the basal forebrain cholinergic system: Role in attention

(2009) J. Fadel et al.   BRAIN RESEARCH

Integrative Physiology of Orexins and Orexin Receptors

(2009) Michihiro Mieda et al.   CNS & Neurological Disorders-Drug Targets

The brain hypocretins and their receptors: mediators of allostatic arousal

(2009) Matthew E Carter et al.   CURRENT OPINION IN PHARMACOLOGY

Comparative Tolerability of Newer Agents for Insomnia

(2009) Gary Zammit   DRUG SAFETY

Emerging drugs for insomnia: new frontiers for old and novel targets

(2009) Shannon S Sullivan et al.   EXPERT OPINION ON EMERGING DRUGS

Systemic and intrabasalis administration of the orexin-1 receptor antagonist, SB-334867, disrupts attentional performance in rats

(2009) Karen E. Boschen et al.   PSYCHOPHARMACOLOGY

Benzodiazepine and Risk of Hip Fractures in Older People: A Nested Case-Control Study in Taiwan

(2008) Chia-Ming Chang et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Emerging anti-insomnia drugs: tackling sleeplessness and the quality of wake time

(2008) Keith A. Wafford et al.   NATURE REVIEWS DRUG DISCOVERY

Ethanol's Molecular Targets

(2008) R. A. Harris et al.   Science Signaling